303 related articles for article (PubMed ID: 20554641)
21. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Park ES; Park CI; Chang HC; Park CW; Lee DS
Clin Rehabil; 2006 Aug; 20(8):668-74. PubMed ID: 16944824
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin a injection into calf muscles for treatment of spastic equinus in cerebral palsy: a controlled trial comparing sonography and electric stimulation-guided injection techniques: a preliminary report.
Kwon JY; Hwang JH; Kim JS
Am J Phys Med Rehabil; 2010 Apr; 89(4):279-86. PubMed ID: 20068435
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).
Hoare BJ; Wallen MA; Imms C; Villanueva E; Rawicki HB; Carey L
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD003469. PubMed ID: 20091546
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites.
Sätilä H; Pietikäinen T; Iisalo T; Lehtonen-Räty P; Salo M; Haataja R; Koivikko M; Autti-Rämö I
Am J Phys Med Rehabil; 2008 May; 87(5):386-94. PubMed ID: 18427220
[TBL] [Abstract][Full Text] [Related]
25. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
Kim H; Kolaski K
NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of spasticity in cerebral palsy with botulinum toxin].
Calderón-González R; Calderón-Sepúlveda RF
Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Dynamic Equinus Foot Deformity in Children with Cerebral Palsy: A Randomized Controlled Trial.
Chang HJ; Hong BY; Lee SJ; Lee S; Park JH; Kwon JY
Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28820439
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin treatment of spastic equinus in cerebral palsy: a randomized trial comparing two injection sites.
Sätilä H; Iisalo T; Pietikäinen T; Seppänen RL; Salo M; Koivikko M; Autti-Rämö I; Haataja R
Am J Phys Med Rehabil; 2005 May; 84(5):355-65; quiz 366-7, 392. PubMed ID: 15829782
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure.
Mall V; Heinen F; Kirschner J; Linder M; Stein S; Michaelis U; Bernius P; Lane M; Korinthenberg R
J Child Neurol; 2000 Apr; 15(4):214-7. PubMed ID: 10805185
[TBL] [Abstract][Full Text] [Related]
30. Development of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.
Placzek R; Siebold D; Funk JF
Toxins (Basel); 2010 Sep; 2(9):2258-71. PubMed ID: 22069684
[TBL] [Abstract][Full Text] [Related]
31. Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.
Fazzi E; Maraucci I; Torrielli S; Motta F; Lanzi G
J Child Neurol; 2005 Aug; 20(8):661-6. PubMed ID: 16225811
[TBL] [Abstract][Full Text] [Related]
32. Impact of Injection-Guiding Techniques on the Effectiveness of Botulinum Toxin for the Treatment of Focal Spasticity and Dystonia: A Systematic Review.
Grigoriu AI; Dinomais M; Rémy-Néris O; Brochard S
Arch Phys Med Rehabil; 2015 Nov; 96(11):2067-78.e1. PubMed ID: 25982240
[TBL] [Abstract][Full Text] [Related]
33. Parameters for predicting favorable responses to botulinum toxin in children with cerebral palsy.
Fattal-Valevski A; Giladi N; Domanievitz D; Zuk L; Masterman R; Harel S; Wientroub S; Hayek S
J Child Neurol; 2002 Apr; 17(4):272-7. PubMed ID: 12088083
[TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
35. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
36. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
37. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
38. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
39. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
Mackey AH; Miller F; Walt SE; Waugh MC; Stott NS
Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
[TBL] [Abstract][Full Text] [Related]
40. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
